Clinical Trial Update: A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate [Phase 3]

View source ↗

Summary

Phase 3 trial update providing long-term safety follow-up and examining long-term exposure to abiraterone acetate in metastatic castration-resistant prostate ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Castration-resistant Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Metastatic Castration-resistant Prostate Cancer, Metastatic Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2022-05-10